New Delhi: Coronavirus continues to wreak havoc in the country. While efforts are on to break the chain of infection, on the other hand, efforts are being made to accelerate the vaccination campaign. Meanwhile, on Thursday, Health Member of the NITI Aayog, Dr. VK Paul has given a big piece of information about the Sputnik Vaccine. He said I am happy to say that we hope that it will be available in the market next week. We expect limited supply sales from there (Russia) to start next week. ” Paul said this at a press conference on the coronavirus.
Paul said, “” After this, the supply will also increase. Its production will start in July and it is estimated that 15.6 crore doses will be produced in that period. ”
The third place in the fastest vaccination campaign
The NITI Aayog member said, “Around 18 crore doses of the corona vaccine have been administered in India. In the US, this number is around 26 crores. Therefore, India is in third place. “
He said, “We are happy to inform that a third of people 45 and above have been vaccinated and are now protected.” 88% of people in the age group of 45 and above die. So you can guess how much he must have done to reduce the risk of death of this population. “
Must be vaccinated after 6 months
Dr. Paul said, “This was discussed by the National Technical Advisory Group on Vaccination and scientists said that if a person is infected, he develops antibodies and is safe.” Scientists say that a person should get vaccinated 6 months after recovering. “
216 crore vaccine to be manufactured by December
Paul went on to say, “Overall, 216 crore doses of vaccines will be manufactured in India between August and December in India and for Indians. There is no doubt that we will have the vaccine available to move forward. ”
He said, “Any vaccine approved by FDA, WHO can come to India. Import license will be given within 1-2 days. No import license is pending. “
All companies given help
The NITI Aayog member said, “The Department of Biotechnology, the other depots concerned, MEA has been in contact with Pfizer, Moderna, Johnson & Johnson since inception. They were officially asked if they wanted to send a dose to India or manufacture, we will find a partner and help. ”
He further states that, “The companies had stated that they were working in their own way and would talk about the availability of the vaccine in 2021 in Q3. We are connected to them. I hope they will move forward to increase availability in India. “
Companies invited to manufacture vaccine
Dr. VK Paul said, “We invite them to build here with our companies. Johnson & Johnson did a good job, they accepted the offer under the quad. “
Who wants to make come forward?
Dr. VK Paul said, “People say that Kovaxin is given to other companies for manufacturing. I am happy to say that the Kovacsin manufacturing company (Bharat Biotech) has welcomed it when we discussed it with them. The living virus is inactivated under this vaccine and it is done only in BSL3 laboratories. ”
He said, “Not every company has this. We extend an open invitation to companies that wish to do so. Companies that want to manufacture covaxin should do so together. The government will help so that capacity increases. “
